JD Supra: Mergers

MAY 8, 2024

By: Paul Hastings LLP

Trading 180

Trading 180

How2Exit

APRIL 8, 2024

b' E202: M&A for Entrepreneurs: Leverage Acquisitions to Scale Your Business Faster with Dominic Wells - Watch Here rn rn About the Guest(s): rn Dominic Wells is an accomplished entrepreneur and the CEO of Onfolio, a publicly traded company specializing in the acquisition of online businesses.

M&A 130

M&A Acquisitions Business Public Trading 130

Peak Frameworks

AUGUST 15, 2023

Insider trading , a highly controversial topic in financial ethics and law, involves the trading of a public company's stock by individuals with access to non-public, material information about the company. Contrary to popular belief, not all insider trading is illegal.

Trading 52

Trading Financial Market Stock Investors 52

The TRADE

APRIL 25, 2024

However, despite this, Joe Collery, head of trading at Comgest endorsed a measured approach whilst speaking at TradeTech earlier this week. With innovation rife across the emerging markets space, it should come as no surprise that plans for further investment are picking up pace.

Trading 62

Trading Investors Portfolio Management Investment 62

How2Exit

SEPTEMBER 25, 2023

b' rn How PE Should Support Portfolio Company Acquisitions | Barak Routhenstein w/ Kison Patel rn rn rn watch here: rn rn rn How2Exit Sponsor: rn rn Reconciled provides industry-leading virtual bookkeeping and accounting services for busy business owners and entrepreneurs across the US.

M&A 130

M&A Acquisitions Portfolio Private Equity 130

Transactional Delights

OCTOBER 17, 2023

When I was a corporate communications intern at AOL Time Warner (pre-Columbus Circle), we used to do a daily search through the newspapers and cut out clips mentioning the company, directly and indirectly. Initial trading suggests some skepticism for whether this deal will consummate. Everything always comes back full circle.

Media 52

Media Stock Hospitality Shares 52

Cooley M&A

JANUARY 23, 2024

Strained access to public markets and funding The IPO market remained relatively inactive in 2023, leading many life sciences companies looking to raise funds to turn to other exit strategies. Additional major acquisitions of 2023 included Pfizer’s acquisition of Seagen for $43 billion and Merck’s acquisition of Prometheus for $10.8

M&A 52

M&A Mergers and Acquisitions Pharmaceutical Acquisitions 52